Skip to content

Clinical trials

Macular Edema trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Edema Country / region: China Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20133
20141
20151
20163
20172
20196
20203
20212
20223
20232
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting6
Unknown status6
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Allergan3
Bayer2
Chengdu Kanghong Biotech Co., Ltd.2
Hoffmann-La Roche2
Peking Union Medical College Hospital2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Sun Yat-sen University2
Affiliated Hospital of Nantong University1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Edema32
Retinal Vein Occlusion14
Vision Disorders5
Diabetic Retinopathy4
Diabetes Mellitus2
Uveitis2
Choroidal Neovascularization1
Cone-Rod Dystrophies1
Diabetes Mellitus, Type 21
Epiretinal Membrane1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.